BREIJ; Esther Cornelia Wilhelmina
Patent Applications and Registrations
Patent applications and USPTO patent grants for BREIJ; Esther Cornelia Wilhelmina.The latest application filed is for "axl antibody-drug conjugates for use in treating cancer".
- BREIJ; Esther Cornelia Wilhelmina - Utrecht NL
| Patent | Date |
|---|---|
| Axl Antibody-drug Conjugates For Use In Treating Cancer App 20220273809 - JANMAAT; Maarten ; et al. | 2022-09-01 |
| Anti-tissue Factor Antibody-drug Conjugates And Their Use In The Treatment Of Cancer App 20210030888 - RANGWALA; Reshma Abdulla ; et al. | 2021-02-04 |
| Monoclonal antibodies against CD32b Grant 9,663,578 - Van Den Brink , et al. May 30, 2 | 2017-05-30 |
| Monoclonal Antibodies Against Cd32b App 20150004177 - VAN DEN BRINK; Edward Norbert ; et al. | 2015-01-01 |
| Monoclonal antibodies against CD32B Grant 8,802,089 - Van Den Brink , et al. August 12, 2 | 2014-08-12 |
| Monoclonal Antibodies Against Cd32b App 20110038869 - Van Den Brink; Edward Norbert ; et al. | 2011-02-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 